Tens of millions of Americans entrust their health to generics and biosimilars. This publication introduces you to some of them.
Thanks to generic and biosimilar medicines, the U.S. health care system saved $338 billion in 2020, and nearly $2.4 trillion in the last decade. Generic medicines fill nine out of 10 prescriptions in the U.S. but are responsible for only 18% of the country’s spending on drugs. While costly brand-name products account for the bulk of pharmaceutical spending, AAM member companies bring costs down. During a time when we all have gained a greater appreciation of health and health care, I am honored to take part in this work.
Physicians, pharmacists, patients and caregivers across the country trust generics and biosimilars. Here are their stories, in their own words—along with perspectives from health care professionals and the AAM team.
Click here for mobile-friendly version.
